BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17634645)

  • 1. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy.
    Zheng Y; Newhauser W; Fontenot J; Taddei P; Mohan R
    Phys Med Biol; 2007 Aug; 52(15):4481-96. PubMed ID: 17634645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system.
    Wang X; Sahoo N; Zhu RX; Zullo JR; Gillin MT
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1563-70. PubMed ID: 20097484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the secondary neutral radiation in proton therapy: toward an indirect in vivo dosimetry.
    Carnicer A; Letellier V; Rucka G; Angellier G; Sauerwein W; Herault J
    Med Phys; 2012 Dec; 39(12):7303-16. PubMed ID: 23231280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit.
    Zheng Y; Fontenot J; Taddei P; Mirkovic D; Newhauser W
    Phys Med Biol; 2008 Jan; 53(1):187-201. PubMed ID: 18182696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neutron dose equivalent from the Mevion S250 proton accelerator: measurements and calculations.
    Chen KL; Bloch CD; Hill PM; Klein EE
    Phys Med Biol; 2013 Dec; 58(24):8709-23. PubMed ID: 24301001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.
    Zacharatou Jarlskog C; Lee C; Bolch WE; Xu XG; Paganetti H
    Phys Med Biol; 2008 Feb; 53(3):693-717. PubMed ID: 18199910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of neutron dose equivalent for a proton therapy center using uniform scanning proton beams.
    Zheng Y; Liu Y; Zeidan O; Schreuder AN; Keole S
    Med Phys; 2012 Jun; 39(6):3484-92. PubMed ID: 22755728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams.
    Polf JC; Newhauser WD
    Phys Med Biol; 2005 Aug; 50(16):3859-73. PubMed ID: 16077232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient neutron dose equivalent exposures outside of the proton therapy treatment field.
    Polf JC; Newhauser WD; Titt U
    Radiat Prot Dosimetry; 2005; 115(1-4):154-8. PubMed ID: 16381704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary neutron doses for several beam configurations for proton therapy.
    Shin D; Yoon M; Kwak J; Shin J; Lee SB; Park SY; Park S; Kim DY; Cho KH
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):260-5. PubMed ID: 19362245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdosimetry distributions for 40-200 MeV protons.
    Palajová Z; Spurný F; Davídková M
    Radiat Prot Dosimetry; 2006; 121(4):376-81. PubMed ID: 16782987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
    DeMarco J; Kupelian P; Santhanam A; Low D
    Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Configuration and validation of an analytical model predicting secondary neutron radiation in proton therapy using Monte Carlo simulations and experimental measurements.
    Farah J; Bonfrate A; De Marzi L; De Oliveira A; Delacroix S; Martinetti F; Trompier F; Clairand I
    Phys Med; 2015 May; 31(3):248-56. PubMed ID: 25682475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility studies of a passive scatter proton therapy nozzle without a range modulator wheel.
    Harvey MC; Polf JC; Smith AR; Mohan R
    Med Phys; 2008 Jun; 35(6):2243-52. PubMed ID: 18649454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental validation of the TOPAS Monte Carlo system for passive scattering proton therapy.
    Testa M; Schümann J; Lu HM; Shin J; Faddegon B; Perl J; Paganetti H
    Med Phys; 2013 Dec; 40(12):121719. PubMed ID: 24320505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility.
    Paganetti H; Jiang H; Lee SY; Kooy HM
    Med Phys; 2004 Jul; 31(7):2107-18. PubMed ID: 15305464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study.
    Bues M; Newhauser WD; Titt U; Smith AR
    Radiat Prot Dosimetry; 2005; 115(1-4):164-9. PubMed ID: 16381706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls of tungsten multileaf collimator in proton beam therapy.
    Moskvin V; Cheng CW; Das IJ
    Med Phys; 2011 Dec; 38(12):6395-406. PubMed ID: 22149823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective generation of the spread-out-Bragg peak from the laser accelerated proton beams using a carbon-proton mixed target.
    Yoo SH; Cho I; Cho S; Song Y; Jung WG; Kim DH; Shin D; Lee SB; Pae KH; Park SY
    Australas Phys Eng Sci Med; 2014 Dec; 37(4):635-44. PubMed ID: 25154880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.